Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions
Atopic Dermatitis, Psoriasis, Alopecia
About this trial
This is an interventional treatment trial for Atopic Dermatitis focused on measuring UVA1, UVB, atopic dermatitis, psoriasis, alopecia, mycosis fungoides (CTCL), urticaria, inflammatory dermatoses, stretch marks
Eligibility Criteria
Inclusion Criteria: Ages: 10-80 years Clinical diagnosis of inflammatory dermatoses such as atopic dermatitis, psoriasis, mycosis fungoides, alopecia areata, and urticaria. No disease states or physical conditions that would impair evaluation of the test site. Willing and able to receive UVA1 or UVB, as directed in the protocol; make evaluation visits; and follow protocol restrictions. Signed, written, witnessed, informed consent form. Must live within a reasonable driving distance of Ann Arbor, Michigan, and/or be able to attend all of the scheduled appointments during the study. Exclusion Criteria: History of photosensitivity (development of hives or bumps with exposure to light). UVA1 or UVB irradiation hypersensitivity in a UVA1/UVB photo-provocation test. Pregnant or nursing women. Involved in an investigational study within the previous 4 weeks. Presence of bacterial superinfection. Taken oral therapy for skin condition within the last 4 weeks Topical steroid therapy within the last 2 weeks History of excessive scar formation or keloids
Sites / Locations
- University of Michigan Department of Dermatology
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
UVA1 Irradiation
UVB Irridiation
UVA 1 Irradiation (Sellemed UVA1 light source) up to 130 J/cm2
UVB Irradiation maximum dose of 4000 mJ/cm2